Colloidal Gold · Respiratory Infections
Influenza A/B Antigen Detection Kit (Colloidal Gold)
Qualitative detection of influenza A and B virus antigens in oropharyngeal and nasopharyngeal swab specimens to aid in the diagnosis of influenza A and B viral infections.
- SKU Code
AENE-RT130- Approval
- On request
- Product Type
- Assay / Kit
- Status
- Available
Qualitative detection of influenza A and B virus antigens in oropharyngeal and nasopharyngeal swab specimens to aid in the diagnosis of influenza A and B viral infections.
| Product type | Assay / Kit |
|---|---|
| Technology platform | Colloidal Gold |
| Application area | Respiratory Infections |
Epidemiology
Commonly known as the flu, influenza is an Orthomyxoviridae virus with a segmented negative-sense RNA genome. Classification into types A, B, and C is based on antigenic variations in nucleocapsid (NP) and matrix (M) proteins; a recently identified D type adds to this grouping. Types A and B are the predominant causes of human influenza, characterized by widespread transmission and high infectivity. Clinical presentation typically includes systemic symptoms such as high fever, fatigue, headache, cough, and generalized muscle aches, with relatively mild respiratory signs. The infection can be severe—even fatal—in young children, older adults, and immunocompromised individuals. Influenza A viruses mutate rapidly and are responsible for multiple global pandemics; they are further subtyped into 16 hemagglutinin (HA) and 9 neuraminidase (NA) variants based on antigenic properties. Influenza B mutates at a slower rate than A, yet still triggers localized outbreaks and seasonal epidemics.
| SKU code | AENE-RT130 |
|---|---|
| Target region | influenza A and B influenza virus antigens |
| Storage temperature | 4℃-30℃ |
| Sample type | Oropharyngeal swab, Nasopharyngeal swab |
| Shelf life | 24 months |
| Auxiliary instruments | Not required |
| Extra Consumables | Not required |
| Detection time | 15-20 mins |
| Specificity | There is no cross-reactivity with the pathogens such as Adenovirus, Endemic Human Coronavirus (HKU1), Endemic Human Coronavirus (OC43), Endemic Human Coronavirus (NL63), Endemic Human Coronavirus (229E), Cytomegalovirus, Enterovirus, Parainfluenza virus, measles virus, human metapneumovirus, Popularity mump virus, Respiratory syncytial virus type B, Rhinovirus, Bordetella pertussis, C. pneumoniae, Haemophilus influenzae, Mycobacterium tuberculosis, Mycoplasma pneumoniae, Neisseria meningitidis, Staphylococcus and etc. |
| Approval | On request |
|---|---|
| Documents | Datasheet, IFU, SDS, COA / conformance, origin, and export documents where available |
FAQ
What should be confirmed before quotation?
Sample context, collection method, and extraction workflow should be confirmed before final kit selection.
Which documents can be requested?
Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.
Can the format be adjusted for different workflows?
Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.
Inquiry
Send the essentials for a useful first reply.
Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-RT130 to the right quote or sample discussion.